Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.
Related Posts
How a Leading Chain of Psychiatric Hospitals Traps Patients
Acadia Healthcare is holding people against their will to maximize insurance payouts, a Times investigation found.
What to Know About Plague After a New Case in California
It is not just a scourge of the Middle Ages. Plague still exists, though it is rare. Here’s what to…
Even Grave Errors at Rehab Hospitals Go Unpenalized and Undisclosed
For-profit hospitals provide most inpatient physical therapy but tend to have worse readmission rates to general hospitals. Medicare doesn’t tell…